Di Brizzi, E.V. (2023) “Effectiveness and Safety After a Switch to Tildrakizumab: A Real World Multicenter Italian Study in Psoriasis”, Dermatology Practical & Conceptual, 13(4), p. e2023215. doi:10.5826/dpc.1304a215.